Terpinen-4-ol as an Antibacterial and Antibiofilm Agent against Staphylococcus aureus
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Staphylococcus aureus is able to rapidly develop mechanisms of resistance to various drugs and to form strong biofilms, which makes it necessary to develop new antibacterial drugs. The essential oil of Melaleuca alternifolia is used as an antibacterial, a property believed to be mainly due to the presence of terpinen-4-ol. Based on this, the objective of this study was to evaluate the antibacterial and antibiofilm potential of terpinen-4-ol against S. aureus. The Minimal Inhibitory and Minimal Bactericidal Concentrations (MIC and MBC) of terpinen-4-ol were determined, and the effect of its combination with antibacterial drugs as well as its activity against S. aureus biofilms were evaluated. In addition, an in silico analysis of its pharmacokinetic parameters and a molecular docking analysis were performed. Terpinen-4-ol presented a MIC of 0.25% (v/v) and an MBC of 0.5% (v/v) (bactericidal action); its association with antibacterials was also effective. Terpinen-4-ol has good antibiofilm activity, and the in silico results indicated adequate absorption and distribution of the molecule in vivo. Molecular docking indicated that penicillin-binding protein 2a is a possible target of terpinen-4-ol in S. aureus. This work highlights the good potential of terpinen-4-ol as an antibacterial product and provides support for future pharmacological studies of this molecule, aiming at its therapeutic application.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420 · cited 3×
“Violations of the rules of Lipinski [36], Ghose [37], Veber [38], and Egan [39] help to evaluate the pharmacokinetic characteristics of drug candidates.”
BackgroundMethodTong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192 · cited 1×
“Staphylococcus aureus is a Gram-positive bacterial species capable of efficiently circumventing the body’s defense barriers, through its virulence mechanisms [1].”
BackgroundStrategies for combating bacterial biofilm infections
Wu, H., Moser, C., Wang, H.-Z., Høiby, N., & Song, Z.-J. (2015) · International Journal of Oral Science · doi:10.1038/ijos.2014.65 · Cited by 925 · cited 2×
“However, few studies have been carried out to assess the potential for rupture of already formed biofilms which, once established, are difficult to remove and are responsible for high rates of therapeutic failure [33].”
BackgroundEssential Oils, A New Horizon in Combating Bacterial Antibiotic Resistance
Yap, P. S. X., Yiap, B. C., Ping, H. C., & Lim, S. H. E. (2014) · The Open Microbiology Journal · doi:10.2174/1874285801408010006 · Cited by 426
Kaplan, J. B., Izano, E. A., Gopal, P., Karwacki, M. T., Kim, S., Bose, J. L., Bayles, K. W., & Horswill, A. R. (2012) · mBio · doi:10.1128/mbio.00198-12 · Cited by 287
Cited by
Antimicrobial Activity of Individual Volatile Compounds from Various Essential Oils
Brandes, A., Dunning, M., & Langland, J. (2024) · Molecules · doi:10.3390/molecules29081811 · Cited by 29
Nair, V. G., Unnikrishnan, V. K., Muralidharan, N., Venkatathri, B. N. S., Lowrence, R. C., YBRD, R., Narbhavi, D., A, A., N, P., & Nagarajan, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-17404-4 · Cited by 8
“The findings diverge from earlier terpene studies 44,45 , which focused on plant-derived compounds or different mechanisms, positioning probiotic-derived metabolites as a promising, low-toxicity alternative for overcoming multidrug resistance and advancing microbiome-inspired antimicrobial…”
Metadata
- Authors
- Cordeiro, L., Figueiredo, P., Souza, H., Sousa, A., Andrade-Júnior, F., Medeiros, D., Nóbrega, J., Silva, D., Martins, E., Barbosa-Filho, J., & Lima, E.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-06-25
- Volume
- 21
- Issue
- 12
- Pages
- 4531
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3037963447
- Cited by
- 144
- References
- 5
- FWCI
- 8.12
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.